Breithardt, G., & Hacke, W. (2014). Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. European heart journal, 35(47), . https://doi.org/10.1093/eurheartj/ehu305
Chicago-Zitierstil (17. Ausg.)Breithardt, Günter, und Werner Hacke. "Clinical Characteristics and Outcomes with Rivaroxaban Vs. Warfarin in Patients with Non-valvular Atrial Fibrillation but Underlying Native Mitral and Aortic Valve Disease Participating in the ROCKET AF Trial." European Heart Journal 35, no. 47 (2014). https://doi.org/10.1093/eurheartj/ehu305.
MLA-Zitierstil (9. Ausg.)Breithardt, Günter, und Werner Hacke. "Clinical Characteristics and Outcomes with Rivaroxaban Vs. Warfarin in Patients with Non-valvular Atrial Fibrillation but Underlying Native Mitral and Aortic Valve Disease Participating in the ROCKET AF Trial." European Heart Journal, vol. 35, no. 47, 2014, https://doi.org/10.1093/eurheartj/ehu305.